Autopsy report · NCT02136706

Feasibility and Diagnostic Accuracy of Myocardial SPECT Using Early Imaging Protocol

“Sponsor and site were unable to complete a final contract to support the study”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Medhat Osman MD

Sponsor type

US federal agency

Conditions

Coronary Artery Disease; Atherosclerosis

Interventions

Myocardial Perfusion imaging with 10 minute waiting period

Participants

0

Trials that died the same way

• Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera
  “The study was terminated by the sponsor” (77% match in meaning)
• Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients
  “Study terminated by the Sponsor” (76% match in meaning)
• Parkinson's Disease G2019S LRRK2 Genetic Testing Program
  “Sponsor stopped the study” (76% match in meaning)
• Visual Function Tests in Age-related Macular Degeneration
  “Study terminated by Sponsor” (76% match in meaning)
• Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302
  “Study was stopped by the Sponsor” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.